Skip to main content
Caplight Logo









Actipulse Neuroscience

Actipulse Neuroscience

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://actipulseneuroscience.com/

Last Round

Seed

Feb 27, 2022

Total Funding Raised

$1.23M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Actipulse Neuroscience is a medical technology company that specializes in developing non-invasive brain stimulation technologies for the treatment of psychiatric and neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share

AI Layer

Non-AI

Keywords

neuromodulationtranscranial magnetic stimulationTMSbrain stimulationmedical devicemental health techdepression treatmentnon-invasive therapyhome-use medical devicetreatment-resistant depressionpsychiatric deviceportable neuromodulationbrain healthneurotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Actipulse Neuroscience Comparables

Compare Actipulse Neuroscience with similar companies based on industry and business-model similarity.

Actipulse Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neurolief
87%
Flow Neuroscience
83%
Sooma
83%

Actipulse Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 27, 2022
SeedJan 25, 2022
SAFENov 17, 2021
AcceleratorOct 30, 2019
GrantMay 4, 2018

Actipulse Neuroscience Investors

Notable investors and investment history

Actipulse Neuroscience investors
InvestorRounds
Start-Up ChileGrant
MassChallenge IsraelAccelerator
Y CombinatorSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 147% MoM.

  • Feb 27, 2022

    $500K round led by Y Combinator

Actipulse Neuroscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Actipulse Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Actipulse Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range24
Year Founded2017
Last FundingFeb 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?